Eikonizo Therapeutics Headquarters & Office Locations

Smart therapy developer. Headquarters: 700 Main Street, North Amherst, Massachusetts 02139, United States.

Headquarters
North Amherst, MA
Total locations
3
Employees · est. 2026
15

Identity graph

Eikonizo Therapeutics headquarters, locations and relationships

Headquarters700 Main Street, North Amherst, Massachusetts 02139, United StatesOpen in Google Maps
Legal name
Eikonizo Therapeutics, Inc.
Industry
Biotechnology
Founded
2017

Eikonizo Therapeutics office locations

3 total
Eikonizo Therapeutics office locations: headquarters and key locations
CityState / regionCountryType
North AmherstMassachusettsUnited StatesHeadquarters
BeverlyMassachusettsUnited StatesOffice
CambridgeMassachusettsUnited StatesOffice
Parent company
No parent company recorded in GraphIQ.ai.

Verified from public filings, company websites and news · Methodology

Open in GraphIQ.ai

More Eikonizo Therapeutics data in GraphIQ.ai

This page shows the public record. Sign in with a work email to open the rest of the entity.

  • Technographics (available after sign-in)

    Software, cloud and infrastructure in use.

  • Firmographics (available after sign-in)

    Revenue, headcount, growth and industry codes.

  • Capabilities (available after sign-in)

    Products, services and certifications.

  • News (available after sign-in)

    Recent coverage and signals, resolved to the entity.

  • And more (available after sign-in)

    Subsidiaries, people and lookalike companies.

Who uses the Eikonizo Therapeutics entity

  • Revenue and GTM teams

    Territories, enrichment and account expansion on one resolved account.

    RevOps Sales & marketing
  • Industry and supply chain

    Suppliers, sites and partners mapped to the right legal entity.

    Industry
  • Private equity and investors

    Corporate family, comparable companies and deal sourcing.

    Private equity
  • Government and public sector

    Supplier vetting, ownership and jurisdiction checks against one verified entity.

    Government
  • Developers and AI agents

    The entity and its relationships through the REST API and MCP server.

    Developers

About Eikonizo Therapeutics

Eikonizo Therapeutics is headquartered in North Amherst, Massachusetts, United States. Founded in 2017, the company has 3 recorded locations and employs approximately 15 people worldwide.

Where is Eikonizo Therapeutics's main office?

Eikonizo Therapeutics's main headquarters office is located at 700 Main Street, North Amherst, Massachusetts 02139, United States. This is the company's primary corporate address.

Eikonizo Therapeutics regional offices

Beyond its headquarters in North Amherst, Eikonizo Therapeutics has recorded locations in United States.

Eikonizo Therapeutics contact information

The main switchboard for Eikonizo Therapeutics headquarters can be reached at +1 617 302 6817. Official website: eikonizo.com.

What does Eikonizo Therapeutics do?

Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Their first program is focused on a disease-modifying therapeutics for neurodegenerative diseases.

One entity, every stage

Put Eikonizo Therapeutics to work across your revenue bowtie

All use cases
  1. Target Define the market Build the account list from companies shaped like your best customers, Eikonizo Therapeutics included. Fingerprint search 
  2. Cover Plan territories Eikonizo Therapeutics's 3 locations roll up to one account, so it lands in one territory, once. Territory planning 
  3. Engage Act on timing Leadership changes, funding and M&A arrive linked to the account, not a loose headline. Signal monitoring 
  4. Convert Close on a resolved record Inbound and closed-won attach to one CRM record, with no duplicates to merge. CRM enrichment 
  5. Retain Ground every answer Customer teams and AI agents answer from the same entity, with a source and a date. AI agent data layer 
  6. Expand Find the next buyer inside Follow subsidiaries and divisions to the next team that can buy. Account expansion 

About the source

What is GraphIQ.ai?

A B2B identity graph. It resolves each organization into one verified entity and maps its parent and subsidiaries, employees, competitors and news signals. Revenue teams use it in the product; AI agents query it through the REST API and MCP server.

POST/api/v2/organizations/search

Eikonizo Therapeutics: frequently asked questions

Where is Eikonizo Therapeutics headquarters?

700 Main Street, North Amherst, Massachusetts 02139, United States.

What is Eikonizo Therapeutics's phone number?

+1 617 302 6817 (headquarters).

When was Eikonizo Therapeutics founded?

2017.

How many employees does Eikonizo Therapeutics have?

About 15, as of October 2026 (GraphIQ.ai estimate).

How many offices does Eikonizo Therapeutics have?

3 locations, including Beverly, Cambridge.

Questions about GraphIQ.ai

Is GraphIQ.ai a list of companies like a spreadsheet?

No. Each organization resolves to one verified entity linked to its parent, subsidiaries, people and signals, so Eikonizo Therapeutics here is the same Eikonizo Therapeutics in your CRM, territory plan and agent answers.

Where does this Eikonizo Therapeutics data come from?

Public filings, company websites and news, resolved to one entity and continuously updated.

Find more info on Eikonizo Therapeutics using GraphIQ

Revenue teams waste hours stitching together data from a dozen tools before a single rep can make a meaningful touch. GraphIQ fixes that. Whether you're building target account lists, routing inbound leads, or keeping your CRM clean as Eikonizo Therapeutics's structure evolves, GraphIQ gives you verified company, people and location data in one place.

From territory planning and lead scoring to handoff workflows and pipeline hygiene, our platform connects the data your GTM engine needs to run without friction. Sign up today and see how GraphIQ helps your revenue team spend less time finding information and more time acting on it.

287MOrganizations resolved
393MEmployees
2B+News and events